Brooks, C., Sheu, T., Bridges, K., Mason, K., Kuban, D., Mathew, P., & Meyn, R. (2012). Preclinical evaluation of sunitinib, a multi-tyrosine kinase inhibitor, as a radiosensitizer for human prostate cancer. BioMed Central.
Citação norma ChicagoBrooks, Colin, Tommy Sheu, Kathleen Bridges, Kathy Mason, Deborah Kuban, Paul Mathew, and Raymond Meyn. Preclinical Evaluation of Sunitinib, a Multi-tyrosine Kinase Inhibitor, As a Radiosensitizer for Human Prostate Cancer. BioMed Central, 2012.
Citação norma MLABrooks, Colin, et al. Preclinical Evaluation of Sunitinib, a Multi-tyrosine Kinase Inhibitor, As a Radiosensitizer for Human Prostate Cancer. BioMed Central, 2012.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.